Citation: | YANG Xiaoying, QIN Cheng, ZHAO Bangbo, LI Tianhao, CAO Hongtao, WANG Weibin. Detection Technology and Prospects of Clinical Application of Circulating Tumor Cells in Pancreatic Cancer[J]. JOURNAL OF MECHANICAL ENGINEERING, 2021, 12(5): 768-773. doi: 10.12290/xhyxzz.2020-0005 |
[1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70: 7-30. doi: 10.3322/caac.21590
|
[2] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66: 115-232. doi: 10.3322/caac.21338
|
[3] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68: 7-30. doi: 10.3322/caac.21442
|
[4] |
Motosugi U, Ichikawa T, Morisaka H, et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT[J]. Radiology, 2011, 260: 446-453. doi: 10.1148/radiol.11103548
|
[5] |
Becker AE, Hernandez YG, Frucht H, et al. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection[J]. World J Gastroenterol, 2014, 20: 11182-11198. doi: 10.3748/wjg.v20.i32.11182
|
[6] |
Lee J, Park SS, Lee YK, et al. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA[J]. Mol Oncol, 2019, 13: 1623-1650. doi: 10.1002/1878-0261.12537
|
[7] |
Malafa MP, Permuth J, Chen D. MicroRNA assay for detection and management of pancreatic cancer precursors[P]. U.S. Patent, 2019, 10: 240.
|
[8] |
Yang ZJ, LaRiviere MJ, Ko J, et al. A multi-analyte panel consisting of extracellular vesicle miRNAs and mRNAs, cfDNA, and CA19-9 shows utility for diagnosis and staging of pancreatic adenocarcinoma[J]. Clin Cancer Res, 2020, 26: 3248-3258. doi: 10.1158/1078-0432.CCR-19-3313
|
[9] |
Bernard V, Kim DU, San LFA, et al. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer[J]. Gastroenterology, 2019, 156: 108-118. doi: 10.1053/j.gastro.2018.09.022
|
[10] |
Ashworth TR. A case of cancer in which cells similar to those in the tumours were seen in the blood after death[J]. Aust Med J, 1869, 14: 146.
|
[11] |
乔雪峰, 张玉娟, 崔巍. 循环肿瘤细胞致肿瘤血行转移研究进展[J]. 协和医学杂志, 2014, 5: 331-334. doi: 10.3969/j.issn.1674-9081.2014.03.017
|
[12] |
Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells[J]. Nat Rev Cancer, 2008, 8: 329-340. doi: 10.1038/nrc2375
|
[13] |
Vaidyanathan R, Soon RH, Zhang P, et al. Cancer diagnosis: from tumor to liquid biopsy and beyond[J]. Lab Chip, 2018, 19: 11-34. http://www.ncbi.nlm.nih.gov/pubmed/30480287
|
[14] |
Hao S, Wan Y, Xia Y, et al. Size-based separation methods of circulating tumor cells[J]. Adv Drug Deliv Rev, 2018, 125: 3-20. doi: 10.1016/j.addr.2018.01.002
|
[15] |
Vona G, Sabile A, Louha M, et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells[J]. Am J Pathol, 2000, 156: 57-63. doi: 10.1016/S0002-9440(10)64706-2
|
[16] |
Burinaru TA, Avram M, Avram A, et al. Detection of Circulating Tumor Cells Using Microfluidics[J]. ACS Comb Sci, 2018, 20: 107-126. doi: 10.1021/acscombsci.7b00146
|
[17] |
Riethdorf S, O'Flaherty L, Hille C, et al. Clinical applications of the CellSearch platform in cancer patients[J]. Adv Drug Deliv Rev, 2018, 125: 102-121. doi: 10.1016/j.addr.2018.01.011
|
[18] |
Went PT, Lugli A, Meier S, et al. Frequent EpCam protein expression in human carcinomas[J]. Hum Pathol, 2004, 35: 122-128. doi: 10.1016/j.humpath.2003.08.026
|
[19] |
Khoja L, Backen A, Sloane R, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker[J]. Br J Cancer, 2012, 106: 508-516. doi: 10.1038/bjc.2011.545
|
[20] |
杨卓, 张玉娟, 陈倩, 等. 循环肿瘤细胞检测及其特性[J]. 协和医学杂志, 2013, 4: 191-194. doi: 10.3969/j.issn.1674-9081.2013.02.023
|
[21] |
Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology[J]. Nature, 2007, 450: 1235-1239. doi: 10.1038/nature06385
|
[22] |
Iwanicki-Caron I, Basile P, Toure E, et al. Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis[J]. Am J Gastroenterol, 2013, 108: 152-155. doi: 10.1038/ajg.2012.367
|
[23] |
Zhang W, Bao L, Yang S, et al. Tumor-selective replication herpes simplex virus-based technology signifi-cantly improves clinical detection and prognostication of viable circulating tumor cells[J]. Oncotarget, 2016, 7: 39768-39783. doi: 10.18632/oncotarget.9465
|
[24] |
Chang C, Huang W, Jalal SI, et al. Circulating tumor cell detection using a parallel flow micro-aperture chip system[J]. Lab Chip, 2015, 15: 1677-1688. doi: 10.1039/C5LC00100E
|
[25] |
Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede pancreatic tumor formation[J]. Cell, 2012, 148: 349-361. doi: 10.1016/j.cell.2011.11.025
|
[26] |
Rhim AD, Thege FI, Santana SM, et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions[J]. Gastroenterology, 2014, 146: 647-651. doi: 10.1053/j.gastro.2013.12.007
|
[27] |
Cauley CE, Pitman MB, Zhou J, et al. Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings[J]. J Am Coll Surg, 2015, 221: 699-707. doi: 10.1016/j.jamcollsurg.2015.05.014
|
[28] |
Kamande JW, Hupert ML, Witek MA, et al. Modular microsystem for the isolation, enumeration, and phenotyping of circulating tumor cells in patients with pancreatic cancer[J]. Anal Chem, 2013, 85: 9092-9100. doi: 10.1021/ac401720k
|
[29] |
Court CM, Ankeny JS, Sho S, et al. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer[J]. Ann Surg Oncol, 2018, 25: 1000-1008.
|
[30] |
Kulemann B, Pitman MB, Liss AS, et al. Circulating tumor cells found in patients with localized and advanced pancreatic cancer[J]. Pancreas, 2015, 44: 547-550. doi: 10.1097/MPA.0000000000000324
|
[31] |
Klapman J, Malafa MP. Early detection of pancreatic cancer: why, who, and how to screen[J]. Cancer Control, 2008, 15: 280-287. doi: 10.1177/107327480801500402
|
[32] |
Soeth E, Grigoleit U, Moellmann B, et al. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival[J]. J Cancer Res Clin Oncol, 2005, 131: 669-676. doi: 10.1007/s00432-005-0008-1
|
[33] |
Kurihara T, Itoi T, Sofuni A, et al. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result[J]. J Hepatobiliary Pancreat Surg, 2008, 15: 189-195. doi: 10.1007/s00534-007-1250-5
|
[34] |
de Albuquerque A, Kubisch I, Breier G, et al. Multi-marker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study[J]. Oncology, 2012, 82: 3-10. doi: 10.1159/000335479
|
[35] |
Bidard FC, Huguet F, Louvet C, et al. Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial[J]. Ann Oncol, 2013, 24: 2057-2061. doi: 10.1093/annonc/mdt176
|
[36] |
Gao Y, Zhu Y, Zhang Z, et al. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization[J]. J Exp Clin Cancer Res, 2016, 35: 66. doi: 10.1186/s13046-016-0340-0
|
[37] |
Poruk KE, Valero V, Saunders T, et al. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma[J]. Ann Surg, 2016, 264: 1073-1081. doi: 10.1097/SLA.0000000000001600
|
[38] |
Stephenson D, Nahm C, Chua T, et al. Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis[J]. Oncotarget, 2017, 8: 107223-107236. doi: 10.18632/oncotarget.19928
|
[39] |
Effenberger KE, Schroeder C, Hanssen A, et al. Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer[J]. Clin Cancer Res, 2018, 24: 2844-2850. doi: 10.1158/1078-0432.CCR-18-0120
|
[40] |
Chang M, Chang Y, Chen J, et al. Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma[J]. Clin Chem, 2016, 62: 505-513. doi: 10.1373/clinchem.2015.248260
|
[41] |
Catenacci DV, Chapman CG, Xu P, et al. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound[J]. Gastroenterology, 2015, 149: 1794-1803. doi: 10.1053/j.gastro.2015.08.050
|
[42] |
Bissolati M, Sandri MT, Burtulo G, et al. Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer[J]. Tumour Biol, 2015, 36: 991-996. doi: 10.1007/s13277-014-2716-0
|
[43] |
Tien YW, Kuo H, Ho B, et al. A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases[J]. Medicine (Baltimore), 2016, 95: e3407. doi: 10.1097/MD.0000000000003407
|
[44] |
Nagrath S, Jack RM, Sahai V, et al. Opportunities and Challenges for Pancreatic Circulating Tumor Cells[J]. Gastroenterology, 2016, 151: 412-426. doi: 10.1053/j.gastro.2016.05.052
|